Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 agonists. More patients using albuterol ...

Please provide your email address to receive an email when new articles are posted on . Patients who used the Reliever Digihaler System had greater odds for better asthma control compared with ...

person holding blue asthma inhaler Researchers examined real-world characteristics of patients receiving albuterol multidose dry powder inhaler or short-acting β2 agonists with short-acting β2 ...

Asthma is a common lung condition that affects 5.4 million people in the UK and can lead to symptoms such as coughing, wheezing or feeling breathless. Asthma is best controlled by regular use of a ...

Please provide your email address to receive an email when new articles are posted on . The meta-analysis included 27 unique randomized controlled trials and 50,496 patients. Combinations improved ...

As reliever monotherapy for mild asthma, the inhaled corticosteroid (ICS)-formoterol combination reduced asthma attacks in children compared with a short-acting β₂-agonist (SABA), the CARE trial ...

“Be wary of [SABA] overuse. It is for when the patient has poor control of their symptoms, but should not be used for routine treatment,” said Holmes, a general practitioner (GP) partner at The Park ...

Asthma is a chronic lung condition characterized by inflammation and narrowness in the airways that carry air in and out of the lungs. About 1 in 13 people in the United States are affected by asthma.

Researchers have found that more than a quarter of asthma patients are still over-using inhalers intended for rapid relief of symptoms. Overuse of these inhalers is linked to an increased risk of ...